Azulfidine and Obstructive airways disorder - a phase IV clinical study of FDA data
Obstructive airways disorder is reported only by a few people who take Azulfidine.
The phase IV clinical study analyzes which people take Azulfidine and have Obstructive airways disorder. It is created by eHealthMe based on reports of 7,443 people who have side effects while taking Azulfidine from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
7,443 people reported to have side effects when taking Azulfidine.
Among them, 4 people (0.05%) have Obstructive airways disorder.
What is Azulfidine?
Azulfidine has active ingredients of sulfasalazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 7,544 Azulfidine users for its effectiveness, alternative drugs and more.
What is Obstructive airways disorder?
Obstructive airways disorder (a progressive disease that makes it hard to breathe) is found to be associated with 1,922 drugs and 1,072 conditions by eHealthMe.
Number of Azulfidine and Obstructive airways disorder reports submitted per year:
Gender of people who have Obstructive airways disorder when taking Azulfidine *:
- female: 50 %
- male: 50 %
Age of people who have Obstructive airways disorder when taking Azulfidine *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 25 %
- 40-49: 50 %
- 50-59: 0.0 %
- 60+: 25 %
Common drugs people take besides Azulfidine *:
- Humira: 1 person, 25.00%
Common side effects people have besides Obstructive airways disorder *:
- Abdominal Pain Upper: 2 people, 50.00%
- Diarrhea: 2 people, 50.00%
- Peripheral Swelling: 2 people, 50.00%
- Pain: 2 people, 50.00%
- Nausea And Vomiting: 2 people, 50.00%
- Kidney Stones: 2 people, 50.00%
- Joint Swelling: 2 people, 50.00%
- Chest Pain: 2 people, 50.00%
- Headache (pain in head): 2 people, 50.00%
- Dry Mouth: 2 people, 50.00%
Common conditions people have *:
- Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 1 person, 25.00%
- High Blood Cholesterol: 1 person, 25.00%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 25.00%
* Approximation only. Some reports may have incomplete information.
Do you take Azulfidine and have Obstructive airways disorder?Check whether Obstructive airways disorder is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Obstructive airways disorder and when was it recovered:
Expand to all the drugs that have ingredients of sulfasalazine:
Alternative drugs to, pros and cons of Azulfidine:
- Azulfidine (7,544 reports)
Common Azulfidine side effects:
Browse all side effects of Azulfidine:a b c d e f g h i j k l m n o p q r s t u v w x y z
Obstructive airways disorder treatments and more:
- Obstructive airways disorder (13,464 reports)
COVID vaccines that are related to Obstructive airways disorder:
- Obstructive airways disorder in Moderna COVID Vaccine
- Obstructive airways disorder in Pfizer BioNTech Covid Vaccine
- Obstructive airways disorder in Johnson and Johnson Covid Vaccine
Common drugs associated with Obstructive airways disorder:
All the drugs that are associated with Obstructive airways disorder:
- Obstructive airways disorder (1,922 drugs)
Common conditions associated with Obstructive airways disorder:
All the conditions that are associated with Obstructive airways disorder:
- Obstructive airways disorder (1,072 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on sulfasalazine (the active ingredients of Azulfidine) and Azulfidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pemetrexed and Jaw Fracture - 23 seconds ago
- Hypomania and Radiculopathy - 25 seconds ago
- Northera and Aspirin drug interaction - 27 seconds ago
- Bortezomib and Endocarditis - 31 seconds ago
- Isoniazid and Oncovin drug interaction - 49 seconds ago
- Remicade and Prinzide drug interaction - 59 seconds ago
- Deferiprone and Transplant Failure - a minute ago
- Gentamicin and Truvada drug interaction - a minute ago
- Calcium Carbonate and Fall - a minute ago
- Sanctura and Skin Blushing/Flushing - a minute ago